BILL vs STRO
Bill Com Holdings Inc (BILL) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported BILL revenue for 2025-06-30 was $1.46B. Net income was $23.8M. Revenue was up 13.4% from 2024-06-30 to 2025-06-30. BILL currently screens at market cap $4.78B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
BILL currently screens at market cap $4.78B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the BILL and STRO stock pages for the full models.
Not investment advice.